Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    gadolin
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Obinutuzumab;   Drug: Bendamustine

Study has passed its completion date and status has not been verified in more than two years.